
Check out the positive review of Gilead Sciences Inc's hepatitis C drug - Sofosbuvir given by the ‘U.S. Food and Drug Administration’ (FDA).
Gilead Sciences’ much-anticipated hepatitis C drug, named as Sofosbuvir, has been given the thumbs up by an FDA advisory group. All 15 members of the Food and Drug Administration’s panel of virus experts have...